Business Wire

Inauguration of CMA Terminals Khalifa Port Boosts the Port’s Total Container Capacity by 23% to almost 10m TEUs

Share

With the new CMA CGM Terminal, Khalifa Port becomes the regional hub headquarters for three of world’s top five shipping companiesCMA Terminals Khalifa Port will play a vital role in enhancing UAE inland and maritime connectivityThe sustainably designed container terminal is operated under a 35-year concession by a joint venture between CMA CGM & AD Ports GroupThe completed phase 1 of CMA Terminals Khalifa Port cost AED 3.1 billion (USD 845 million), and adds 1.8 million TEUs capacity to Khalifa Port

AD Ports Group (ADPORTS:ADX), an enabler of integrated trade, transport and logistics solutions, announced the inauguration of CMA Terminals Khalifa Port, a state-of-the-art, AED 3.1 billion (USD 845 million) container terminal by His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241212510462/en/

null

HH Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, Rodolphe Saadè, Captain Mohamed Al Shamisi during the inauguration of CMA Terminals Khalifa Port (Photo: AETOSWire)

The inauguration is a major milestone in the development of Khalifa Port, AD Ports Group’s flagship port. The world-class container, ro-ro, and multipurpose port facility opened in December 2012, and in just 12 years has expanded to become one of the world’s fastest-growing, most efficient commercial ports.

CMA Terminals Khalifa Port, managed by a joint venture between the CMA CGM Group’s subsidiary CMA Terminals (70%) and AD Ports Group (30%), showcases advanced port infrastructure, including automated gates and integrated systems that enhance efficiency and sustainability. The facility offers shore-power for vessels to limit emissions, several solar panels areas contributing to the energy mix of the terminal operations and includes the region’s first net zero carbon administration building, which is powered by renewable energy sources. The building won the Net Zero Building Project of the Year Award in 2022 from the MENA Green Building Awards.

The addition of the CMA CGM facility increases Khalifa Port’s annual container capacity by 23% to almost 10 million TEUs (Twenty Foot Equivalent Units). The new terminal is ready for rail connectivity and will significantly enhance Khalifa Port’s position as a major gateway for the region. The design of the new facility incorporates sustainability principles into the construction which support the UAE’s wider targets for building the circular economy, recycling construction and reducing operational waste.

The new facility includes eight advanced Ship to Shore (STS) cranes, and 20 Electric Rubber Tyred Gantry (e-RTG) cranes, which enhances Khalifa Port’s reputation as one of the world’s most technologically advanced commercial ports, underscoring Abu Dhabi’s role in driving the future of sustainable and smart trade.

H.E. Mohamed Hassan Alsuwaidi, Chairman of AD Ports Group, said: “The inauguration of CMA Terminals Khalifa Port highlights the UAE as a premier investment destination and solidifies its position as a key partner for global players. The new terminal will boost trade flows and foster long-term economic growth in Abu Dhabi and the UAE.”

Rodolphe Saadé, Chairman and Chief Executive Officer of the CMA CGM Group, said: “The inauguration of our new container terminal is a major step in the development of Khalifa Port, consolidating Abu Dhabi's position as a global trade hub. This strategic infrastructure will boost shipping and logistics activities across the region. Together with our partner AD Ports Group, we are pleased to deliver a modern terminal with a strong focus on innovation and sustainability.”

Captain Mohamed Juma Al Shamisi, Managing Director and Group CEO, AD Ports Group, said: “CMA Terminals Khalifa Port will significantly boost Abu Dhabi’s connectivity, reinforcing its vital role on the global trade map and contributing to local economic diversification in line with the vision of our leadership. This new facility places AD Ports Group firmly in the ranks of the world’s leading global port operators. We look forward to a long, mutually beneficial partnership with CMA CGM that brings long-term economic benefits to the UAE and Abu Dhabi, as we work together to build a sustainable global transport future.”

The inauguration of CMA Terminals Khalifa Port marks the completion of Phase 1 of the new terminal project for CMA CGM, with the opening of an initial quay wall of 800 metres 18.5 metres of depth, and 8 STS Cranes adding a total capacity of 1.8 million TEUs (Twenty Foot Equivalent Units) to Khalifa Port.

With the opening of the new CMA CGM facility, Khalifa Port has reached a new stage as one of the region’s leading port trade hubs. Khalifa Port now extends over 6.3 km2, with 41 quay cranes, 159 yard cranes, 11.7 km of quay wall and 3.8 km of breakwater length.

Source: AETOSWire

View source version on businesswire.com: https://www.businesswire.com/news/home/20241212510462/en/

null

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release

Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release

Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye